205 related articles for article (PubMed ID: 3550308)
41. Dialysis-related beta 2 microglobulin-amyloid arthropathy. Improvement of clinical symptoms after a switch of dialysis membranes.
Hardouin P; Flipo RM; Foissac-Gegoux P; Dumont A; Duquesnoy B; Delcambre B
Clin Rheumatol; 1988 Mar; 7(1):41-5. PubMed ID: 3044672
[TBL] [Abstract][Full Text] [Related]
42. Antiproteases and dialysis arthropathy.
Docci D; Baldrati L; Capponcini C; Neri L; Feletti C
Nephrol Dial Transplant; 1994; 9(8):1204-6. PubMed ID: 7528361
[No Abstract] [Full Text] [Related]
43. Beta-2-microglobulin amyloidosis and osteo-articular pathology of the uremic patient on regular dialysis.
Brancaccio D; Anelli A; Gallieni M; Padovese P; Coggi G; Uslenghi C
Contrib Nephrol; 1990; 77():177-86. PubMed ID: 2188786
[No Abstract] [Full Text] [Related]
44. Hemodialysis-associated amyloidosis of bone of beta-2 microglobulin origin.
Mikawa Y; Watanabe R; Yamano Y
Arch Orthop Trauma Surg; 1990; 109(2):109-12. PubMed ID: 2180389
[TBL] [Abstract][Full Text] [Related]
45. Beta-2 microglobulin in renal disease.
Miyata T; Jadoul M; Kurokawa K; Van Ypersele de Strihou C
J Am Soc Nephrol; 1998 Sep; 9(9):1723-35. PubMed ID: 9727382
[No Abstract] [Full Text] [Related]
46. Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis.
Iida Y; Miyata T; Inagi R; Sugiyama S; Maeda K
Biochem Biophys Res Commun; 1994 Jun; 201(3):1235-41. PubMed ID: 8024566
[TBL] [Abstract][Full Text] [Related]
47. Dialysis amyloidosis.
van Ypersele de Strihou C; Honhon B; Vandenbroucke JM; Huaux JP; Noël H; Maldague B
Adv Nephrol Necker Hosp; 1988; 17():401-21. PubMed ID: 3124550
[No Abstract] [Full Text] [Related]
48. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
Gejyo F; Homma N; Arakawa M
Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
[TBL] [Abstract][Full Text] [Related]
49. Amyloid arthropathy.
Rowe IF
Ann Rheum Dis; 1985 Nov; 44(11):727-8. PubMed ID: 4062385
[No Abstract] [Full Text] [Related]
50. Clinical picture of the amyloid arthropathy in patients with chronic renal failure maintained on haemodialysis using cellulose membranes.
Muñoz-Gómez J; Gómez-Pérez R; Llopart-Buisán E; Solé-Arqués M
Ann Rheum Dis; 1987 Aug; 46(8):573-9. PubMed ID: 3310926
[TBL] [Abstract][Full Text] [Related]
51. Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature.
Gal R; Korzets A; Schwartz A; Rath-Wolfson L; Gafter U
Arch Pathol Lab Med; 1994 Jul; 118(7):718-21. PubMed ID: 8024407
[TBL] [Abstract][Full Text] [Related]
52. Amyloid arthropathy in haemodialysed patients.
Muñoz-Goméz J; Solé Arqués M
Ann Rheum Dis; 1986 Oct; 45(10):879-80. PubMed ID: 3789824
[No Abstract] [Full Text] [Related]
53. [Amyloidosis associated with long-term hemodialysis. Report of a case].
Iannicelli E; Salvini V; Chianta GL; Drudi FM; Girolamo MD; Passariello R
Radiol Med; 1997; 94(1-2):102-4. PubMed ID: 9424633
[No Abstract] [Full Text] [Related]
54. New aspects in the pathogenesis of dialysis-related amyloidosis: role of beta 2-microglobulin modified with advanced glycation end products in bone and joint destruction.
Miyata T; Maeda K
Nephrol Dial Transplant; 1996; 11 Suppl 2():140-3. PubMed ID: 8804015
[No Abstract] [Full Text] [Related]
55. [Mediators of amyloidogenesis and cytokines in dialysis-related amyloidosis].
Rysavá R; Merta M; Tesar V; Lachmanová J; Sulková S; Bláha J
Cas Lek Cesk; 2002 Apr; 141(8):244-7. PubMed ID: 12038073
[TBL] [Abstract][Full Text] [Related]
56. [Amyloidosis associated with dialysis].
Mátyus J; Kakuk G
Orv Hetil; 1995 Mar; 136(11):587-93. PubMed ID: 7700615
[TBL] [Abstract][Full Text] [Related]
57. Dialysis arthropathy.
Lancet; 1988 Jan 2-9; 1(8575-6):27-8. PubMed ID: 2891893
[No Abstract] [Full Text] [Related]
58. Serum alpha-1-antitrypsin in hemodialysis patients with dialysis arthropathy.
Docci D; Bilancioni R; Baldrati L; Capponcini C; Delvecchio C; Feletti C
Int J Artif Organs; 1993 Mar; 16(3):123-7. PubMed ID: 8314633
[TBL] [Abstract][Full Text] [Related]
59. Persistence of beta 2-microglobulin amyloid 10 years after renal transplantation.
Kessler M; Aymard B; Pourel J
Nephrol Dial Transplant; 1994; 9(3):333-4. PubMed ID: 8052450
[No Abstract] [Full Text] [Related]
60. Does dialysis-associated amyloidosis resolve after transplantation?
Nelson SR; Sharpstone P; Kingswood JC
Nephrol Dial Transplant; 1993; 8(4):369-70. PubMed ID: 7685506
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
